Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
P. Petersen (København, Denmark). Association between biomarkers at discharge and risk of readmission after community-acquired pneumonia – a retrospective cohort study. 4519

Member's Comments

No comment yet.

Related content which might interest you: The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Risk factors for community-acquired pneumonia in hospitalized adult patients, a case-control study Source: Eur Respir J 2006; 28: Suppl. 50, 351s Year: 2006 The impact of hyperglycemia on community-acquired pneumonia: A retrospective cohort study Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Epidemiology and outcomes in hospitalized patients with health-care-associated pneumonia (HCAP) and community-acquired pneummonia (CAP)~ A prospective observational cohort analysis Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study Source: Eur Respir J, 55 (5) 2000524; 10.1183/13993003.00524-2020 Year: 2020 The glycemic gap and 90-day mortality in community-acquired pneumonia- A prospective cohort study Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017 The effects of antibiotic therapy at the pre-hospital stage on the in-hospital mortality in adults with community-acquired pneumonia in Russia: observational study results. Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 On improving assessment of in-hospital mortality and ICU admisison in community-acquired pneumonia patients by using the e-CURB Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 New evidence of risk factors for community-acquired pneumonia: a population-based study Source: Eur Respir J 2008; 31: 1274-1284 Year: 2008 Psychosocial predictors for rapid hospital readmission in COPD: a prospective study Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 Clinical outcomes of HIV-infected patients hospitalized with community-acquired pneumonia: Results from CAPO international cohort study Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010 Clinical stability predictors and length of stay in adults with community-acquired pneumonia. Prospective cohort Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors Source: Eur Respir J 2016; 47:1572-1574 Year: 2016 Etiology of community-acquired pneumonia requiring hospitalization in Chile: a prospective study Source: Eur Respir J 2005; 26: Suppl. 49, 255s Year: 2005 Predictive factors of in-hospital mortality of patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 352s Year: 2006 Risk factors and implications for readmission of patients following hospitalization for community-acquired pneumonia in South Korea Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 An RDW-based score predicts mid-term mortality in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation study Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Clinical examination and all-cause mortality in non-mild COPD population – prospective study Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019 Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009